Human medicines European public assessment report (EPAR): Augtyro, repotrectinib, Date of authorisation: 13/01/2025, Status: Authorised
Exelon-H-C-PSUSA-00002654-202401 : EPAR - Scientific conclusions and grounds for the variation to the terms of the marketing authorisation
Human medicines European public assessment report (EPAR): Telmisartan Actavis, telmisartan, Date of authorisation: 29/09/2010, Revision: 15, Status: Authorised
Human medicines European public assessment report (EPAR): Darunavir Krka, darunavir, Date of authorisation: 26/01/2018, Revision: 11, Status: Authorised
HMPC: overview of assessment work - priority list
Agenda - PDCO agenda of the 28-31 January 2025 meeting
UPD registration guide for UI and API users
Minutes of the CAT meeting 4-6 December 2024
Clinical Trials Information System (CTIS): Walk-in clinic - January 2025, Online, European Medicines Agency, Amsterdam, the Netherlands, Broadcast, from 29 January 2025, 16:00 (CET) to 29 January 2025, 17:00 (CET)
Human medicines European public assessment report (EPAR): Trajenta, linagliptin, Date of authorisation: 23/08/2011, Revision: 22, Status: Authorised